Exits
Why Organic Revenue Growth Commands Premium Exit Multiples
March 2026 · 5 min read
Zachary Nippert
Founder, Managing Partner

Buy-and-build works. As a value creation strategy, it's been one of the dominant playbooks in PE for the past two decades. Roll up a fragmented market, capture synergies, expand the addressable base, and exit at a higher multiple than you entered.
But there's a version of the story that doesn't get told enough: the multiple expansion from buy-and-build has been compressing. And the companies that command the highest exit multiples in competitive sale processes aren't the ones with the most acquisitions. They're the ones with the best organic growth.
What the data says about organic versus acquired revenue
Gain.pro's analysis of more than 10,000 private equity transactions is one of the most comprehensive datasets available on what actually drives exit multiples. The finding that stands out: companies with greater than 25% organic revenue CAGR command exit multiples approximately 50% higher than companies with equivalent or greater total revenue growth driven primarily by acquisition.
This isn't a small premium at the margin. It's a structural difference in how buyers value revenue quality. And it has a straightforward explanation: organic revenue tells a story about repeatability, defensibility, and market pull. Acquired revenue tells a story about capital deployment.
Organic growers command 50% higher exit multiples than acquisition-led growers at equivalent revenue scale. (Gain.pro, 10,000+ transactions)
Why buyers pay the premium
When a strategic buyer or a next-round sponsor looks at a company in diligence, they're not just buying current revenue. They're buying the mechanism that produces future revenue. Organic growth is evidence that the mechanism works, that the company has found real product-market fit, that customers are choosing to stay and expand, and that the sales motion is repeatable enough to compound.
Acquired revenue doesn't tell that story. It tells a story about the prior sponsor's capital allocation and integration capability. The next buyer has to underwrite integration risk, culture risk, and the question of whether the acquired revenue would have churned without the combined entity's scale. That uncertainty gets priced in.
Cambridge Associates' research on high organic growers versus slow growers shows a similar dynamic: companies with strong organic CAGR generate approximately 3.0x MOIC versus 2.4x for their slower-growing counterparts, a 25% improvement in returns on top of the multiple premium.
The BCG caveat on buy-and-build
BCG's research on buy-and-build strategies adds important nuance: the multiple arbitrage advantage fades significantly above approximately $25M EBITDA. Below that threshold, the roll-up math often works. Above it, you're increasingly in a market where the next buyer is sophisticated enough to look through the structure and value the underlying organic engine, or lack thereof.
This creates a timing problem for sponsors who have relied heavily on inorganic growth to reach scale. The strategy that got them to $20M EBITDA may not be the strategy that gets them the multiple they need at exit. At some point, the organic growth story has to stand on its own.
What this means for the commercial agenda
If organic revenue quality is what commands the premium, then the commercial agenda at any PE-backed company needs to be oriented around building and demonstrating that quality, not just growing the topline.
Gross retention is the foundation. A company with 88%+ gross retention is telling buyers that customers choose to stay, that the value delivered is real, that the switching cost is high, and that the revenue base is durable. A company with 75% gross retention is telling a different story, no matter how fast the topline is growing.
Net revenue retention is the growth story. NRR above 110% means the existing customer base is expanding faster than it's churning. That's the commercial engine every buyer wants to acquire: a base that grows itself before you spend a dollar on acquisition.
Demand gen economics are the scalability proof. A demand generation engine running on 80%+ margins, built on content, community, and systematized outbound rather than raw headcount, tells buyers the growth is scalable. An engine that requires proportional headcount growth to maintain tells a very different story about what it will cost to sustain after acquisition.
The exit story isn't written at the banker meeting. It's written in the two years of commercial execution before it. Retention, NRR, and demand gen economics are the three numbers that determine which multiple range you're competing in.
The companies that command premium exits have usually been building toward them deliberately, not just growing and hoping the multiple follows. The organic growth premium is real, and it's available to any company willing to sequence their commercial work around earning it.
Ready to put this into practice?
Start a diagnosticMore insights
Why PE-Backed Companies Approach Growth Backwards
Ask a mid-hold leadership team their top commercial priority and you'll hear new logos. That is almost always the wrong place to start.
The Case for Pricing Before Acquisition
Pricing gets scheduled for Q3, then slips a year. That delay is one of the most expensive mistakes in PE-backed commercial execution.